Hutchmed (china) Share Discussion Threads

[sportii] 04/7/2018 10:13

Is this any relevant? - ‘Luye plans to use the same local distributors for Seroquel as AZ,...’
in the 7th June yahoo finance article titled ‘ Seroquel Stepping Stone: How Luye Will Use Seroquel to Expand in Emerging Markets’

[nerdofsteel] 04/7/2018 06:58

It's a great question, I hope we get an answer shortly as Seroquel is extremely important for us at the moment. That importance will start to diminish as Fruquintinib and other drugs gain approval of course, but it's fairly critical at the moment.

[lauders] 04/7/2018 02:14

Am I missing something NofS? The link you supplied doesn't really address what happens re: HCM's involvement. Think an e-mail to the company may be in order or they should at least clarify via an announcement on their website at the very least. As miti 1000 says "Its an important question".

[nerdofsteel] 02/7/2018 09:29

hxxps://www.astrazeneca.com/media-centre/press-releases/2018/astrazeneca-and-luye-pharma-group-enter-agreement-for-rights-to-seroquel-and-seroquel-xr-in-the-uk-china-and-other-international-markets.html

[nerdofsteel] 02/7/2018 07:56

miti, no, planning to do that today

To my mind, whatever contract Chi-Med had with AZ will still be valid and transfer across to Luye as part of the deal

[miti 1000] 02/7/2018 06:52

Nerdofsteel, have you emailed him about Seroquel ? Its an important question.

[nerdofsteel] 29/6/2018 15:34

Just came across this post from Oct 2011 on iii:-

Great little company with an excellent future but short term unfortunately
It's Chinese
It's on AIM
It's jam tomorrow , low revenues loss making
support on chart looks questionable at £2.50 and £2. this dropped to sub 50p in the 08/09 trauma

John09 certainly mis-read what this Co is all about

[nerdofsteel] 29/6/2018 10:17

Interesting article in today's Times regarding Seroquel. AZ sold rights of Seroquel to Luye Pharma, a HK listed company last month including rights to the drug in China.

I assume Chi-Meds deal to sell the drug in China on behalf of AZ transfers contractually to Luye, in other words, we still have the deal in place.

Seroquel sales by Chi-Med in China were $35m in FY17

[lauders] 28/6/2018 02:14

Thank NofS! All looks good. We just await some of that key news now and then we may move higher again. Posting the link in 1520 again so it is live:

[nerdofsteel] 27/6/2018 11:42

Excellent note from Edison published today on ASCO2018 including coverage on Fruquintinib

[nerdofsteel] 27/6/2018 10:36

more coverage
hxxps://jamanetwork.com/journals/jama/article-abstract/2685988

[nerdofsteel] 27/6/2018 10:35

on the subject of Stocktwits, there are currently 283 followers of HCM which has grown from <200 a year ago and <100 2 years ago. More would be welcome!

[thornyone] 27/6/2018 09:25

GW Pharmaceuticals in the news on the Nasdaq yesterday. The company is based in Cambridge UK. Announcement that the US FDA has approved Epidiolex for treatment of epilepsy. Some similarities with HCM. High volume of shares traded. But the share price did not budge at all($144) having reached a peak of $162 a month ago. The reason imho: hype-overload.

[kinkell] 26/6/2018 21:33

Cisk,

Thank you.

[cisk] 26/6/2018 17:27

try stocktwits, seeking alpha

[kinkell] 26/6/2018 15:56

Does anyone know a US bb which features HCM, please?

[nerdofsteel] 22/6/2018 08:19

If Savolitinib gets Breakthrough Therapy Designation from the FDA for NSCLC we can espect peak sales of $2.5bn for that indication alone, with Chi-Med getting royalties of 14-18%

[lauders] 21/6/2018 16:58

Like this part, among others, from that link NofS:

The interesting thing is what happens now. When drug trial results are exceptionally good the pharmaceutical company can apply to the regulators for it to be treated as a breakthrough therapy.

If granted, this allows the business to fast-track the route to market, the idea being that since there is a medical need which has not been met, it should be made available to existing patients as soon as possible.

This, however, is simply an added bonus. If that special status is not granted, the drug still comes to market — it just takes a bit longer.

[nerdofsteel] 21/6/2018 11:06

For anyone who has not read it and is interested, this a great article on HCM from late last year. Anthony Hilton has called it correctly right from the 200p per share days.....

[nerdofsteel] 21/6/2018 10:53

haha stranger things have happened, but I will settle for an mcap of $24bn by 2026 which is 6x what it is today. My forecast is based on a number of metrics.

Is that ambitious?

No, it's actually fairly conservative if the late stage pipeline success continues and all P3 trials are successful. There may be the odd hiccup along the way but I think we will get there.

[cisk] 21/6/2018 08:40

Had a weird dream last night that HCM became the most valuable drug company in the world! I wonder if it could ever happen...

[nimrod22] 20/6/2018 16:11

SP up 3.46% at the moment in US market

[nerdofsteel] 20/6/2018 15:08

yes! surely, must be. I assume they will not consider Fruquintinib or Savolitinib to be Chinese as they are headed by AZ and Lilly but we will have Sulfatinib in the next couple of years and that is wholly owned.

Lots of news due, especially the big one, our first NDA.